AI Insight: Quest Diagnostics' current price sits 6.1% below its high-confidence fair value, indicating moderate undervaluation with valuation methods ranging widely from $166.84 to $522.10, reflecting uncertainty. Financial health is stable, but Monte Carlo analysis reveals high volatility and 55.6% downside risk below current price. This suggests notable risk alongside upside potential toward an expected value of $292.12.